Exane Derivatives Medifast Inc Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Medifast Inc stock. As of the latest transaction made, Exane Derivatives holds 2 shares of MED stock, worth $28. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 524
99.62%
Holding current value
$28
Previous $89,000
100.0%
% of portfolio
0.0%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding MED
# of Institutions
150Shares Held
8.8MCall Options Held
365KPut Options Held
360K-
Jim Simons Renaissance Technologies LLC | New York, Ny904KShares$13 Million0.03% of portfolio
-
Black Rock Inc. New York, NY829KShares$11.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA758KShares$10.9 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY353KShares$5.08 Million0.0% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA295KShares$4.24 Million0.02% of portfolio
About MEDIFAST INC
- Ticker MED
- Exchange NYSE
- Sector Consumer Cyclical
- Industry Personal Services
- Shares Outstandng 11,017,900
- Market Cap $159M
- Description
- Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...